About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Psychiatry, Mental Health and Addictions Research Group at the Vall d'Hebron Research Institute is a multidisciplinary team that over the past 13 years has focused its scientific activity on the research (both nationally and internationally) of clinical, therapeutic and etiopathogenic aspects of:
At international level, it participates and/or coordinates several European projects of great repercussion in the area of mental health. At national level, it is part of the CIBERSAM (Centre for Biomedical Research in Mental Health Network) together with other leading groups, conducting research of excellence.
PMID: 35235998 Journal: Kardiologia Polska Year: 2022 Reference: Kardiol Pol. 2022;80(4):485-488. doi: 10.33963/KP.a2022.0065. Epub 2022 Mar 2. Impact factor: 3.108 Publication type: Paper in international publication Authors: Baneras, Jordi, Kwasiborski, Przemyslaw, Velagapudi, Poonam, Ijioma, Nkechinyere, Trepa, Maria, Fekadu, Chala, Vandenbriele, Christophe, Stratinaki, Maria, Tun, Han Naung, Garaygordobil, Diego Araiza et al. DOI: 10.33963/KP.a2022.0065
PMID: 34928563 Journal: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY Year: 2022 Reference: J Clin Psychopharmacol. 2022 Jan-Feb 01;42(1):75-80. doi: 10.1097/JCP.0000000000001483. Impact factor: 3.153 Publication type: Paper in international publication Authors: Garriga, Marina, Mallorqui, Andrea, Bernad, Sonia, Ruiz-Cortes, Victoria, Oliveira, Cristina, Amoretti, Silvia, Mezquida, Gisela, Bioque, Miquel, Molina, Oriol, Gomez-Ramiro, Marta et al. DOI: 10.1097/JCP.0000000000001483
PMID: 35170748 Journal: ACTA PSYCHIATRICA SCANDINAVICA Year: 2022 Reference: Acta Psychiatr Scand. 2022 Jul;146(1):36-50. doi: 10.1111/acps.13415. Epub 2022 Feb 25. Impact factor: 6.392 Publication type: Paper in international publication Authors: Salagre, Estela, Aedo, Alberto, Salgado-Pineda, Pilar, Montoro Salvatierra, Irene, Sanchez Gistau, Vanessa, Pomarol-Clotet, Edith, Ramos-Quiroga, Josep Antoni, Carvalho, Andre F, Garcia-Rizo, Clemente, Undurraga, Juan et al. DOI: 10.1111/acps.13415
PMID: 34998087 Journal: PSYCHIATRY RESEARCH Year: 2022 Reference: Psychiatry Res. 2022 Feb;308:114349. doi: 10.1016/j.psychres.2021.114349. Epub 2021 Dec 20. Impact factor: 3.222 Publication type: Paper in international publication Authors: Fadeuilhe, C, Daigre, C, Grau-Lopez, L, Richarte, V, Palma-Alvarez, R F, Corrales, M, Saez, B, Baz, M, Ramos-Quiroga, J A et al. DOI: 10.1016/j.psychres.2021.114349
PMID: 34188796 Journal: Therapeutic Advances in Psychopharmacology Year: 2021 Reference: Ther Adv Psychopharmacol. 2021 Jun 16;11:20451253211022187. doi: 10.1177/20451253211022187. eCollection 2021. Impact factor: 5 Publication type: Letter or abstract Authors: Vendrell-Serres, Julia, Soto-Angona, Oscar, Rodriguez-Urrutia, Amanda, Ramos-Quiroga, Josep A, Arteaga-Henriquez, Gara et al. DOI: 10.1177/20451253211022187
PMID: 34187406 Journal: BMC Psychiatry Year: 2021 Reference: BMC Psychiatry. 2021 Jun 29;21(1):321. doi: 10.1186/s12888-021-03330-y. Impact factor: 3.63 Publication type: Paper in international publication Authors: Bonnin, C Mar, Quiroga, Josep Antoni Ramos, Vieta, Eduard, Martin, Gemma Espanol, Lugo-Marin, Jorge, Gisbert-Gustemps, Laura, Ramos, Imanol Setien et al. DOI: 10.1186/s12888-021-03330-y
PMID: 34122179 Journal: Frontiers in Psychiatry Year: 2021 Reference: Front Psychiatry. 2021 May 26;12:663889. doi: 10.3389/fpsyt.2021.663889. eCollection 2021. Impact factor: 4.157 Publication type: Paper in international publication Authors: Palma-Alvarez, Raul F, Fadeuilhe, Christian, Daigre, Constanza, Richarte, Vanesa, Grau-Lopez, Lara, Ramos-Quiroga, Josep A, Corrales, Montse et al. DOI: 10.3389/fpsyt.2021.663889
PMID: 32449368 Journal: ASSESSMENT Year: 2021 Reference: Assessment. 2021 Jul;28(5):1445-1458. doi: 10.1177/1073191120918929. Epub 2020 May 25. Impact factor: 4.667 Publication type: Paper in international publication Authors: Espanol-Martin, Gemma, Pagerols, Mireia, Prat, Raquel, Rivas, Cristina, Sixto, Laura, Valero, Sergi, Artigas, Maria Soler, Ribases, Marta, Ramos-Quiroga, Josep A, Casas, Miquel et al. DOI: 10.1177/1073191120918929
The doctoral training program of excellence led by the UAB TOUCH MSCA-COFUND, focused on the field of mental health, opens its second call until March 31.
Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.
These results reinforce the need for more individualized attention to address educational needs from an early stage.
